• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    More On HIK.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Hikma Pharmaceuticals PLC (HIK.L)

    -LSE
    2,204.00 Down 37.00(1.65%) Apr 29, 11:35AM EDT
    ProfileGet Profile for:
    Hikma Pharmaceuticals PLC
    13 Hanover Square
    London, W1S 1HW
    United Kingdom - Map
    Phone: 44 20 7399 2760
    Fax: 44 20 7399 2761
    Website: http://www.hikma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drugs - Generic
    Full Time Employees:7,139

    Business Summary 

    Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of branded and non-branded generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, Europe, the United Kingdom, and internationally. It operates through three segments: Branded, Injectables, and Generic. The Branded segment offers 377 products in 1,125 dosage forms and strengths in the anti-infective, cardiovascular, diabetes, and central nervous system (CNS) therapeutic areas. The Injectables segment markets 185 products in 488 dosage strengths and forms for CNS, controlled substances, anti-infective, cardiovascular, and oncological therapeutic areas. This segment also offers sterile liquid, powder, lyophilized, and cytotoxic products. The Generics segment provides 26 products in 68 dosage strengths and forms for therapeutic areas, including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory, hormonal, and others. This segment markets its products to chain stores, wholesalers, distributors, health systems, and governmental agencies in the form of tablets, capsules, solutions, and suspensions. The company also offers anesthetics, anti-histamines, gastroenterology and metabolism, musculoskeletal system, dermatology, genitourinary system, transplantation, vitamins and supplements, and miscellaneous products. In addition, it manufactures plastic specialized medicinal sterile containers; and conducts bio-equivalency studies. Hikma Pharmaceuticals PLC was founded in 1978 and is based in London, the United Kingdom.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Hikma Pharmaceuticals PLC

    Key Executives 
     PayExercised
    Mr. Said Samih Taleb Darwazah , 59
    Chairman and Chief Exec. Officer
    N/AN/A
    Mr. Mazen Samih Taleb Darwazah , 58
    Exec. Vice Chairman, Member of Compliance, Responsibility & Ethics Committee, Member of Nomination Committee, Chief Exec. Officer of MENA & Emerging Markets and Pres of MENA & Emerging Markets
    N/AN/A
    Mr. Khalid Nabilsi ,
    Chief Financial Officer
    N/AN/A
    Dr. Ibrahim Jalal ,
    Sr. Corp. VP of Technical Affairs
    N/AN/A
    Ms. Susan Ringdal ,
    VP of Corp. Strategy and Investor Relations
    N/AN/A
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in GBp.